Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled date : 2021 - 05 - 25 save search
Huntington, TCF Announce Receipt Of All Required Regulatory Approvals For Pending Merger
Published: 2021-05-25 (Crawled : 22:00) - prnewswire.com
HBAN F | $13.645 0.85% 0.84% 17M
|
Finance
|
| O: 0.49%
H: 0.68%
C: 0.36%
HBNC | $12.26 1.66% 1.63% 150K
|
Finance
|
| O: 0.68%
H: 2.81%
C: 2.59%
huntington merge approval
Shaw Announces Court of Queen’s Bench Approval of the Plan of Arrangement for the Proposed Business Combination With Rogers
Published: 2021-05-25 (Crawled : 22:00) - globenewswire.com
SJR | $30.18 0.03% 6.4M
|
Consumer Services
|
| O: -0.2%
H: 0.66%
C: 0.0%
approval
ISS Recommends Leaf Group Shareholders Approve Acquisition by Graham Holdings and All Related Proposals
Published: 2021-05-25 (Crawled : 21:00) - globenewswire.com
GHC | $718.9 2.59% 0.0% 11K
|
Consumer Services
|
| O: 0.38%
H: 2.12%
C: 1.19%
acquisition approval
WISeKey Shareholders Approved All Agenda Items of the 2021 Annual General Meeting
Published: 2021-05-25 (Crawled : 17:00) - globenewswire.com
WKEY | News | $1.97 -3.55% 12K
|
Technology Services
|
| O: 1.49%
H: 3.21%
C: -0.54%
approval
ImmunityBio Expands Trials of T-Cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South Africa
Published: 2021-05-25 (Crawled : 13:15) - nantkwest.com
IBRX | $5.48 10.93% 9.85% 31M
|
Manufacturing
|
| O: 2.23%
H: 2.37%
C: -1.93%
covid nasal spray test vaccine trial approval t-cell africa
European Commission approves Ponvory (ponesimod) for the treatment of adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features
Published: 2021-05-25 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.21%
C: -0.35%
multiple sclerosis disease treatment europe sclerosis imaging
Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing
Published: 2021-05-24 (Crawled : 01:00) - biospace.com/
QDEL | News 4 | $40.43 3.45% 3.34% 1.2M
|
Health Technology
|
| O: 0.59%
H: 1.64%
C: -1.16%
test
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.